Advertisement
Advertisement
IRWD
Ironwood Pharmaceuticals, Inc. - Class A
3.58
USDSponsored
+0.06
+1.56%
Jun 18, 09:44 UTC -4
Open
IRWD Earnings Reports
Positive Surprise Ratio
IRWD beat 21 of 41 last estimates.
51%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$123.22M
/$0.28
Implied change from Q1 26 (Revenue/ EPS)
+15.69%
/+16.67%
Implied change from Q2 25 (Revenue/ EPS)
+44.55%
/+100.00%
Ironwood Pharmaceuticals, Inc. - Class A earnings per share and revenue
On May 07, 2026, IRWD reported earnings of 0.24 USD per share (EPS) for Q1 26, missing the estimate of 0.24 USD, resulting in a -1.96% surprise. Revenue reached 106.51 million, compared to an expected 93.93 million, with a 13.39% difference. The market reacted with a -13.66% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of 0.28 USD, with revenue projected to reach 123.22 million USD, implying an increase of 16.67% EPS, and increase of 15.69% in Revenue from the last quarter.
FAQ
What were Ironwood Pharmaceuticals, Inc. - Class A's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Ironwood Pharmaceuticals, Inc. - Class A reported EPS of $0.24, missing estimates by -1.96%, and revenue of $106.51M, 13.39% above expectations.
How did the market react to Ironwood Pharmaceuticals, Inc. - Class A's Q1 2026 earnings?
The stock price moved down -13.66%, changed from $4.83 before the earnings release to $4.17 the day after.
When is Ironwood Pharmaceuticals, Inc. - Class A expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Ironwood Pharmaceuticals, Inc. - Class A's next earnings report?
Based on 4
analysts, Ironwood Pharmaceuticals, Inc. - Class A is expected to report EPS of $0.28 and revenue of $123.22M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement